All filters
Abstracts
A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-US
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Implementation science for HIV prevention using an eHealth program for Spanish-speaking sexual minorities groups in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
High prevalence of hepatitis B virus infection among chronic kidney disease patients
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Time to treatment disfavors patients living with HIV/HCV co-infection
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Videos
Asia-Pacific HIV Clinical Forum 2020 | Session 3: Subtypes, Gender, and Ethnicity: Do They Impact HIV Care
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Abstracts
Prevalence of alcohol and substance use in a sample of patients living with HIV/HCV co-infection who are in routine clinical care receiving antiretroviral therapy
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Videos
Asia-Pacific HIV Clinical Forum 2020 | Session 2: Clinical Aspects of the Implementation of PrEP
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Abstracts
Efficacy and safety of sofosbuvir/velpatasvir for the treatment of patients with chronic hepatitis C genotype 1-6 infection: Integrated analysis of eight Phase 3 clinical trials
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Heterogeneity in priorities for continuing education training among clinicians providing (or not!) HIV and HCV clinical services
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Automated electrochemiluminescence assay could be used for screening hepatitis B and C markers in dried blood spot samples?
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
96 Week efficacy and safety of B/F/TAF in treatment-naïve adults and adults ≥ 50 years
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Tenofovir alafenamide vs tenofovir DF in women: Pooled analysis of 7 clinical trials
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Videos
Asia-Pacific HIV Clinical Forum 2020 | Session 1: Clinical Management of HIV Treatment in Asia
Presented at:
Asia-Pacific HIV Clinical Forum 2020
Abstracts
Associations between hepatitis C and social determinants of health in a sample of injecting drug users living with HIV in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Sociodemographic, health-related factors and behavioral practices among people who inject drugs: Data from the PR NHBS-PWID 3 (2012) and NHBS-PWID 4 (2015)
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Provider-Initiated HIV testing predictors among heterosexuals at increased risk of HIV in Puerto Rico: Data from NHBS – HET cycle, 2016
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Hurricane Maria’s viral impact: HIV care outcomes among substance users in Puerto Rico following hurricane Maria
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Videos
Alterations in the Gut Microbiome of HIV infected patients under Antiretroviral Therapy - Shilpa Ray
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
E-Posters
Alteration of the gut fecal microbiome in HIV infected children on anti-retroviral therapy in Yaounde, Cameroon - Casey Martin,B.S.
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
E-Posters
Comparative analysis of vaginal microbiota sampling using the menstrual cups and high vaginal swabs in HIV-1 infected pregnant women_ Charlotte-Eve Short, MBChB, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
E-Posters
Impact of contraceptive use on vaginal microbiome in adolescent girls_Annette Aldous, MPH
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
E-Posters
Baseline gut microbiome dysbiosis predicts gut microbiome response to ART co-trimoxazole treatment in HIV-positive individuals in rural and urban Zimbabwe - Alessandro Lazzaro, MD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
E-Posters
LACTIN-V Treatment for Recurrent Bacterial Vaginosis_Laurel Lagenaur, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
E-Posters
Mosquito borne parasites in patients newly infected with HIV in relationship with CD4 count and TNFα_Mathew Folaranmi Olaniyan, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020